Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**narasin + nicarbazin** is a fixed-ratio combination drug used primarily in poultry as a feed additive for the prevention of coccidiosis, a parasitic disease of the intestinal tract caused by various *Eimeria* species. This combination contains two active ingredients: - **Narasin:** An ionophore polyether antibiotic produced by fermentation of *Streptomyces aureofaciens*. Narasin disrupts ion gradients in coccidia parasites, interfering with nutrient transport and cell function. - **Nicarbazin:** A chemical anticoccidial agent recognized as an equimolecular complex of 4,4'-dinitrocarbanilide (DNC) and 2-hydroxy-4,6-dimethyl-pyrimidine (HDP). Nicarbazin disrupts the development of coccidia by interfering with energy metabolism and nuclear division. Maxiban (narasin + nicarbazin) acts through a **dual mode of action**: narasin targets the sporozoite stage while nicarbazin mainly impacts merogony, resulting in synergistic activity and reduced resistance compared to single-agent anticoccidials. It is administered orally via feed at concentrations of 40–50 mg/kg for each component and is approved for use in broiler chickens, but not in laying hens, turkeys, or breeding stock. Clinical studies indicate efficacy against multiple *Eimeria* strains, with benefits including prevention of coccidiosis, improved weight gain, feed efficiency, and protection of intestinal integrity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on narasin + nicarbazin.